Novel 3α-methoxyserrat-14-en-21β-ol (PJ-1) and 3β-methoxyserrat-14-en-21β-ol (PJ-2)-curcumin, kojic acid, quercetin, and baicalein conjugates as HIV agents

被引:58
|
作者
Tanaka, Reiko [1 ]
Tsujii, Hiroko [1 ]
Yamada, Takeshi [1 ]
Kajimoto, Tetsuya [1 ]
Amano, Fumio [2 ]
Hasegawa, Junya [3 ]
Hamashima, Yoshio [3 ]
Node, Manabu [3 ]
Katoh, Kayoko [4 ]
Takebe, Yutaka [4 ]
机构
[1] Osaka Univ Pharmaceut Sci, Med Chem Lab, Osaka 5691094, Japan
[2] Osaka Univ Pharmaceut Sci, Lab Biodeferense & Regulat, Osaka 5691094, Japan
[3] Kyoto Pharmaceut Univ, Dept Pharmaceut Mfg Chem, Yamashina Ku, Kyoto 6078414, Japan
[4] Natl Inst Infect Dis, AIDS Res Ctr, Lab Mol Virol & Epidemiol, Shinjuku Ku, Tokyo 1628640, Japan
关键词
Conjugates; 3; alpha-Methoxyserrat-14-en-21; beta-ol; beta-Methoxyserrat-14-en-21; Curcumin; Kojic acid; Quercetin; Baicalein; HIV; C8166-CCR5; cells; ANTI-AIDS AGENTS; HUMAN-IMMUNODEFICIENCY-VIRUS; CANCER CHEMOPREVENTIVE ACTIVITY; SERRATANE-TYPE TRITERPENOIDS; MOUSE SKIN; SCHISANDRA-LANCIFOLIA; BETULINIC ACID; MORONIC ACID; STEM BARK; DERIVATIVES;
D O I
10.1016/j.bmc.2009.05.049
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sixteen novel compounds; 3 alpha-methoxyserrat-14-en-21 beta-ol (1) and 3 beta-methoxyserrat-14-en-21 beta-ol (2) and their curcumin, kojic acid, quercetin, and baicalein conjugates (3)-(18) were designed, synthesized, and evaluated for in vitro anti-HIV-1 reverse transcriptase (RT) activity in infected C8166-CCR5 cells, a human CD4(+) T-lymphocyte cell line. Among them, kojic acid derivatives, 9-12 showed significant biological activity. In particular, the compound 13, the conjugate of two molecules of 3 alpha-methoxyserrat-14-en-21 beta-ol (1) and one molecule of kojic acid, exerted significant anti-HIV activity with an EC50 value of 0.12 mu g/mL. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5238 / 5246
页数:9
相关论文
共 5 条
  • [1] Conjugates of 3α-methoxyserrat-14-en-21β-ol (PJ-1) and 3β-methoxyserrat-14-en-21β-ol (PJ-2) as cancer chemopreventive agents
    Tanaka, Reiko
    Tsujii, Hiroko
    Yamada, Takeshi
    Kajimoto, Tetsuya
    Tokuda, Harukuni
    Arai, Takanari
    Suzuki, Nobutaka
    Hasegawa, Junya
    Hamashima, Yoshio
    Node, Manabu
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (08) : 3368 - 3375
  • [2] Hybrids of 3α-methoxyserrat-14-en-21β-ol (PJ-1) and 3β-methoxyserrat-14-en-21β-ol (PJ-2) and various anti-oxidants as cancer chemopreventive agents
    Tsujii, Hiroko
    Yamada, Takeshi
    Kajimoto, Tetsuya
    Tanaka, Reiko
    Tokuda, Harukuni
    Hasegawa, Junya
    Hamashima, Yoshio
    Node, Manabu
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (06) : 2191 - 2197
  • [3] Chemopreventive effects of a serratane-type triterpenoid, 3α-methoxyserrat-14-en-21β-ol (PJ-1), against rat lung carcinogenesis
    Yamaguchi, Chiharu
    Wanibuchi, Hideki
    Kakehashi, Anna
    Tanaka, Reiko
    Fukushima, Shoji
    [J]. FOOD AND CHEMICAL TOXICOLOGY, 2008, 46 (06) : 1882 - 1888
  • [4] Cancer chemopreventive activity of 3β-methoxyserrat-14-en-21β-ol and several serratane analogs on two-stage mouse skin carcinogenesis
    Tanaka, R
    Shanmugasundaram, K
    Yamaguchi, C
    Ishikawa, Y
    Tokuda, H
    Nishide, K
    Node, M
    [J]. CANCER LETTERS, 2004, 214 (02) : 149 - 156
  • [5] 30-NOR-3-BETA-METHOXYSERRAT-14-EN-21-ONE - 1ST REPORTED NATURAL OCCURRENCE OF A NORSERRATENE TRITERPENE
    CONNER, AH
    HAROMY, TP
    SUNDARALINGAM, M
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1981, 46 (14): : 2987 - 2988